Hereditary Stomach Cancer Syndromes Melyssa Aronson, MS, (C)CGC Senior Genetic Counsellor Zane Cohen Centre Mount Sinai Hospital
Overview • • • •
Different types of gastric (stomach) cancer Features of a hereditary syndrome Hereditary Diffuse Gastric Cancer syndrome (CDH1) Other hereditary conditions • Lynch syndrome • Polyposis conditions • And more..
• Common Q&A about genetic testing
2
Not all stomach cancer is the same…
3
Types of Stomach cancer
4
Types of Stomach cancer
5
Ann Surg Oncol 1999;6:290-7
Intestinal adenocarcinoma (54%) • High incidence geographically • Decreasing incidence world-wide • Male predominance (2:1) • Diagnosed ~60-80 yrs old • H. pylori bacteria • Inflammation -> Metaplasia (Ulcer)
Diffuse-type adenocarcinomas (32%) • Increasing incidence? • No gender preference • Younger age of onset • Poorer prognosis • More common in proximal stomach • Lower association with H. pylori • Signet-ring cell 6 US Gastroenterol Hepatol Rev. 2011 Jun; 7(1): 59–64.
Signet ring cell Cancer (seen in diffuse gastric cancer)
Diffuse Gastric Cancer
8
http://www.hopkinsmedicine.org/gastroenterology_hepatology/_pdfs/esophagus_stomach/gastric_cancer.pdf
Risk factors for gastric cancer • • • • •
Aging Geographic location Smoking Diet? Gastritis (Helicobacter pylori)
http://www.hopkinsmedicine.org/gastroenterology_hepatology/_pdfs/esophagus_stomach/gastric_cancer.pdf
9
Helicobacter Pylori • Nearly 50% of the world population is infected with H. pylori • In Ontario: 29.4% in men, 14.9% women • Increased risk based on: • Age • # sibs • Being non-white (First Nation) • Immigrated to Canada at > age 20 • Higher incidence in Japan, Korea, China
Naja et al. Can J Gastroenterol. 2007 Aug;21(8):501-6.
Risk factors for gastric cancer • • • • • • • • • •
Aging Geographic location Smoking Diet? Gastritis (Helicobacter pylori) Intestinal metaplasia Gastric polyps (adenoma) Chronic gastric ulcer Pernicious anemia Blood group – Type A 11
A quick lesson in genetics!
All cancer is genetic, but NOT all cancer is hereditary.
Ulcer/metaplasia Or look normal!
Malignant tumour
13
Most Cancer is Sporadic!
An example of a sporadic gene mutation: HER2/neu • Makes HER2/neu protein – growth promoting protein • Is tumour HER2 positive, i.e. gene mutation turning on HER2 gene? • If so, drugs like Herceptin can be used to treat that cancer (block HER2 receptors) • NOT hereditary cause of the cancer
15
Sporadic cancer
Hereditary cancer
Features of Hereditary Cancer Families • • • •
Younger ages at diagnosis than the general population Multiple generations affected Multiple cancers in one person Similar types of cancers in one family (or clustering of cancers ie. Breast and ovarian cancer
What is the most common hereditary condition causing stomach cancer? Hereditary Diffuse Gastric Cancer Syndrome (CDH1)
Hereditary Diffuse Gastric Cancer Syndrome
• CDH1 gene • E-cadherin protein • Cell to cell adhesion Inheritance: 50/50 to 1st degree relatives
Diffuse gastric cancer risk in men with CDH1 = 70% to age 80 (95%CI, 59%-80%)
Hansford, S et al. JAMA Oncol. 2015;1(1):23-32.
Diffuse gastric cancer in women with CDH1 = 56% to age 80 (95%CI, 44%-69%).
Hansford, S et al. JAMA Oncol. 2015;1(1):23-32.
Breast cancer (lobular) in women with CDH1 = 42% to age 80 (95%CI, 23%-68%).
Hansford, S et al. JAMA Oncol. 2015;1(1):23-32.
Can gastroscopy find diffuse-type gastric cancer?
24
Cambridge protocol screening • 5 biopsies from 6 sites (30 biopsies min)
Transitional zone
van der Post RS, et al. J Med Genet 2015;52:361–374
Prophylactic total gastrectomy
27
• Most patients do very well • Mild physical symptoms may persist • Need longer term follow-up studies
Screening for HDGC carriers • Prophylactic gastrectomy recommended after age 20 • Annual endoscopy by age 20 • random biopsies x6 of each of the following zones: antrum, transitional zone, body, fundus, cardia. Miniumum of 30 biospies recommended
• MRI and mammography beginning at age 25 (mammogram only after age 69) • Prophylactic mastectomy may be an option • CRC screening based on family history
International criteria (IGCLC) for HDGC (2015) ** Testing offered to individual with cancer Established criteria: • 2 GC regardless of age, at least one confirmed DGC • One case of DGC <40 • Personal or family history of DGC and LBC, one diagnosed <50
• • •
Families in whom testing could be considered: Bilateral LBC or family history of 2 or more cases of LBC <50 A personal or family history of cleft lip/palate in patient with DGC In situ signet ring cells and/or pagetoid spread of signet ring cells
van der Post RS, et al. J Med Genet 2015;52:361–374
How common is CDH1 in diffuse gastric cancer?
34 of 183 cases meeting 2010 criteria had CDH1 mutation (19%) JAMA Oncol. 2015;1(1):23‐32.
J Med Genet August 2015 Vol 52 No 8
Index Case
CDH1 mutation Detection rate
Increase in genetic testing (Zane Cohen Centre) Starting doing panels New diagnosis Family member
33
Mutation identified in individuals with gastric ca (by age of onset) 30
Pick-up of CDH1 = 8-12%
other mutation 25
CDH1 mutation no mutation
20 # of patients
15 10 5 0 <20
20‐29
30‐39
40‐49 age
50‐59
60‐69
70+
Zane Cohen Centre, 2015
34
What are the other syndromes that cause hereditary stomach cancer?
Brain and childhood cancer • Li-Fraumeni (TP53) Breast/ovarian cancer • BRCA2 (?BRCA1)
Colon cancer/polyps • FAP (APC) • Juvenile Polyposis (SMAD4) • Peutz Jeghers Syndrome (STK11)
Diffuse Stomach cancer • CDH1 • CTNNA1
Colon and Uterine • Lynch syndrome (5 genes – MSH2, MLH1)
36
What mutations are seen(Zane Cohen Centre)? • Diffuse gastric cancer (n=49) • 42 (86%) no mutation identified • 4 (8%) CDH1 mutations + 2 variants [HDGC] • 2 (4%) STK11 [Peutz-Jeghers Syndrome] • 2 (4%) MSH2, MLH1 [Lynch syndrome] • 1 (2%) BRCA2 [Hereditary Breast-Ovarian Cancer]
• Intestinal gastric cancer + family history (n=4) • 2 (50%) no mutation • 2 (50%) MSH2 [Lynch syndrome]
• Other (mixed, not specified) + family history/young (n=16) • 6 (38%) no mutation • 8 (50%) MSH2, MLH1 [Lynch syndrome] • 2 (12%) APC [Familial Adenomatous Polyposis]
37
Gastric cancer – hereditary causes
38
Oncology, review article, May 15 2012, Schrader et al
JAMA Oncol. 2015;1(1):23‐32
CTNNA1-Associated Diffuse gastric cancer
40
CTNNA1 (α-catenin) • CTNNA1 role in cell adhesion (intercellular) interacts with CDH1 • Seen in a few unrelated families
JAMA Oncol. 2015;1(1):23‐32. JAMA Oncol. 2015;1(1):23‐32.
Lynch syndrome Colorectum + Endometrium
42
MSH2 MSH6 EPCAM
PMS2
MLH1
Cancer in LS
Huge range – depends on gene/study/gender
Higher in Asia > in MSH2 (~12%)
<5%
Clinical Gastroenterology and Hepatology (2014) Vol. 12, No. 5
Lynch syndrome family
• MSH2 • MLH1
Colon @ 49 Gastric @ 54
Colon @ 42 Endometrial @ 49
• EPCAM • MSH6 • PMS2 Colon @ 38
• • • • •
Other GI cancers Ovarian Urinary cancers < Brain Skin (sebaceous)
45
Estimated penetrance and age of onset of neoplasms in BMMRD Organ
Estimated penetrance (%)
Brain cancer Colorectal cancer adenomas Small bowel cancer adenomas Lymphoma Leukemia Endometrial cancer Urinary tract cancer Other sites#
70 70 >90 10 50 20‐40 10‐40 <10 <10 <10
Age at diagnosis: median, range (yrs) 9 (2‐40) 16 (8‐48) 9 (6‐15) 28 (11‐42) 12 (10‐20) 5 (0.4‐30) 8 (2‐21) (19‐44) (10‐22) (1‐35)
Immunohistochemistry (IHC) Instability (MSI)by AGA, US Multitask Force of CRC, CGA Ref:Microsatellite In Review - Position paper endorsed
Immunohistochemistry (IHC)
Blood
Tumour
MSH2 gene
MSH2 protein
MLH1 gene
MLH1 protein
MSH6 gene
MSH6 protein
PMS2 gene
PMS2 protein
48
Polyposis conditions Familial Adenomatous Polyposis Juvenile Polyposis Peutz-Jeghers Polyposis
49
Polyposis Syndromes Syndrome
Features
Gastric Cancer risk
Gene
Familial Adenomatous Polyposis
10 to 100s of colon polyps in adolescent
Rare (but FG polyps very common)
APC
Juvenile Polyposis
5 to hundreds of juvenile polyps in digestive tract
20% (and polyps very common)
SMAD4
Peutz-Jeghers Syndrome
Polyps in colon, freckling in mouth and around fingers, cancer risk
30%
STK11
50
Peutz-Jeghers Syndrome (PJS) Cancers risk: >90% lifetime risk Organ
Cancer Risk
Ovarian
Usually benign (rare tumour: ovarian sex cord tumour)
5%
Cervical
Adenoma Malignum (rare cancer)
10%
Testicular
Sertoli cell -> gynecomastia
9%
Breast
Infiltrating ductal and papillary
54%
Uterine
CRC
39%
Small bowel
13%
Stomach
29%
Lung
13%
Pancreas
36%
Hereditary Breast and Ovarian Cancer Syndrome Breast + Ovarian cancer
52
Hereditary Breast-Ovarian Cancer syndrome
• BRCA2 • BRCA1
Breast @ 42 Ovarian @ 51
Prostate @ 55
Breast @ 49
• Pancreas • Melanoma • ? Colon or gastric
53
JAMA Oncol. 2015;1(1):23‐32.
Li-Fraumeni Syndrome Childhood brain, sarcoma and early onset breast cancer
55
Li‐Fraumeni Syndrome
TP53 mutation Stomach cancer
Breast @ 32
Brain @ 6 Sarcoma @ 10 56
Common Questions for me…. • Why aren’t high‐risk gastric patients being referred to genetics? • Why does genetic testing begin on individuals with gastric cancer? • If you have stomach cancer: – How do I get referred for genetic testing? – What is involved with genetic testing? – If I was tested years ago and had a normal result, can I be re‐ tested for newer genes? • What if I am unaffected – can I still have genetic testing?
Take home messages • Most stomach cancer is sporadic • Flags for hereditary syndromes: early‐onset cancer, multiple related cancer, multiple relatives affected over generations • The TYPE of stomach cancer (diffuse vs intestinal type) impacts how genetic testing is done • Most common stomach cancer syndrome – HDGC: caused by mutation in CDH1 (lobular breast +DGC)
• Other syndromes can explain diffuse and intestinal cancer (Lynch syndrome, PJS, etc) • Majority of high‐risk looking families have no gene identified!
Thank you!